MIRVASO 3mg / g gel medication leaflet

D11AX21 brimonidine • Dermatologicals | Other dermatological preparations | Other dermatologicals

Brimonidine is a medication used to treat open-angle glaucoma and ocular hypertension. It belongs to the class of alpha-2 adrenergic receptor agonists and works by reducing the production of aqueous humor and increasing its outflow, thereby lowering intraocular pressure.

It is available as eye drops and is typically administered two to three times a day, as directed by a doctor. Brimonidine is effective in preventing optic nerve damage caused by elevated intraocular pressure.

Side effects may include a burning or stinging sensation in the eyes, dry eyes, redness, headache, drowsiness, or dizziness. It is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and should be used with caution in those with severe cardiovascular conditions.

General data about MIRVASO 3mg / g

Substance: brimonidine

Date of last drug list: 01-10-2020

Commercial code: W60936003

Concentration: 3mg / g

Pharmaceutical form: gel

Quantity: 1

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for brimonidine

Concentrations available for brimonidine

0.25mg/ml, 2mg/ml, 3mg/g

Combinations with other substances